Alternative

Arch Therapeutics Reports Positive Preclinical Data from Study of AC5 Surgical Hemostatic Device(TM) in Animals Treated with Brilinta(R) (ticagrelor)

WELLESLEY, MA: AC5(TM) Quickly Stopped Bleeding in Animals Prescribed Platelet Aggregation Inhibitor ...

Simavita Expands Board of Directors by Appointing Craig Holland and Adds Appointment to Upcoming Shareholder Meeting Agenda

SYDNEY, AUSTRALIA: ...

Fennec Pharmaceuticals Provides Corporate Update and Third Quarter Ended September 30, 2014 Financial Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA: SIOPEL 6 Has Enrolled 112 Patients With Study Completion Expected by Year End Safety Data on 100 Patients Expected During Q1 2015 Name Change, Warrant Exchange and Share Consolidation Completed ...

"Don''t Call Us Stoners!" New Market Research Report Surveys the New Cannabis Consumer

LAS VEGAS, NV: Seattle Based Canna Ventures Publishes Inaugural "Cannabis Brand Development Study" Report to Help Cannabis Businesses Build a Successful Consumer Brand ...

Vaporin Announces Sequential Revenue Growth of 100% for the 2014 Third Quarter Ending September 30, 2014

MIAMI, FL: Gross Profit Margins Improve to 49.3% for the 2014 Third Quarter as Compared to 43.2% for the 2014 Second Quarter ...

Response Biomedical Corp. Announces Third Quarter 2014 Financial Results

VANCOUVER, BRITISH COLUMBIA: ...

Kane Biotech Announces Amendment to Private Placement Offering

WINNIPEG, MANITOBA: ...

Arch Therapeutics Will Present at Two Investor Conferences in November

WELLESLEY, MA: ...

Nhale, Inc. (NHLE) Announces Engagement of QualityStocks Investor Relations Services

SCOTTSDALE, AZ: ...

FONAR Announces 1st Quarter Fiscal 2015 Results

MELVILLE, NY: ...